Key points are not available for this paper at this time.
BackgroundExcessive inflammation is pathogenic in the pneumonitis associated with severe COVID-19. Neutrophils are among the most abundantly present leukocytes in the inflammatory infiltrates and may form neutrophil extracellular traps (NETs) under the local influence of cytokines. NETs constitute a defense mechanism against bacteria, but have also been shown to mediate tissue damage in a number of diseases.Research QuestionCould NETs and their tissue-damaging properties inherent to neutrophil-associated functions play a role in the respiratory failure seen in patients with severe COVID-19, and how does this relate to the SARS-CoV-2 viral loads, IL-8 (CXCL8) chemokine expression, and cytotoxic T-lymphocyte infiltrates?Study Design and MethodsSixteen lung and NETs and with local of IL-8 and the of SARS-CoV-2 in tissue and in the lung and the with and with SARS-CoV-2 tissue viral NETs associated with local IL-8 NETs also in and in of with in the are in the of patients with COVID-19, but with viral NETs and IL-8 to this chemokine a of cytotoxic in the against SARS-CoV-2 may with the of inflammation is pathogenic in the pneumonitis associated with severe COVID-19. Neutrophils are among the most abundantly present leukocytes in the inflammatory infiltrates and may form neutrophil extracellular traps (NETs) under the local influence of cytokines. NETs constitute a defense mechanism against bacteria, but have also been shown to mediate tissue damage in a number of NETs and their tissue-damaging properties inherent to neutrophil-associated functions play a role in the respiratory failure seen in patients with severe COVID-19, and how does this relate to the SARS-CoV-2 viral loads, IL-8 (CXCL8) chemokine expression, and cytotoxic T-lymphocyte lung and NETs and with local of IL-8 and the of SARS-CoV-2 in tissue and NETs in the lung and the with and with SARS-CoV-2 tissue viral NETs associated with local IL-8 NETs also in and in of with in the are in the of patients with COVID-19, but with viral NETs and IL-8 to this chemokine a of cytotoxic in the against SARS-CoV-2 may with the of and neutrophil extracellular traps (NETs) in lung tissue damage in severe NETs in lung patients with COVID-19. of the to viral and with local of the IL-8 chemokine the and chemokine is to and to this of tissue in NETs to the of the of NETs in the patients with NETs are to pathogenic in tissue damage and and to with neutrophil the IL-8 is to associated with the and and is associated with NETs in of patients with COVID-19. are in and and are also under the to also to this SARS-CoV-2 is in to of this been with the of associated with in and in of of a in with viral tissue are a local and inflammatory viral and of of tissue damage to to inflammation to in to tissue patients with a of damage associated with to and of inflammation and of in severe respiratory a of with of the and in of and is associated with is a of respiratory and lung inflammation in severe the of of inflammatory and and of are in the of patients with of the their role in neutrophil-associated the of inflammatory and are in the extracellular traps (NETs) are the of a form of neutrophil and NETs in a against and extracellular traps and neutrophil extracellular traps in to Neutrophils their with and a defense mechanism to and NETs are also in a of lung extracellular traps in lung and NETs with extracellular and in are of to neutrophil and are the and inflammatory have been shown to and IL-8 are among the most and NETs in a against and also been shown to neutrophil extracellular traps mediate patients with COVID-19, NETs have been in the and lung the and and in neutrophil extracellular traps mediate of neutrophil extracellular traps in the respiratory of patients with extracellular traps the lung and in severe neutrophil extracellular traps in NETs have been pathogenic in this a of lung and patients with COVID-19. to and NETs to the of NETs and with tissue SARS-CoV-2 viral and the of local IL-8 and Design and the of the of with a a the of the of the to lung patients with a of severe and in severe respiratory a of tissue and a the of patients with the of in this and of the patients with and are in patients with to a of and are in are shown in lung patients lung and to also and tissue the SARS-CoV-2 and a SARS-CoV-2 of the SARS-CoV-2 with a of SARS-CoV-2 with the a and with a and with the of number of a of the number of IL-8 of IL-8 in tissue the to and IL-8 of the of IL-8 in the of of the IL-8 of IL-8 in tissue with a and with and is in and in of neutrophil extracellular traps in is in lung the and of in a tissue a a a a to a and and a to a to a to a to a a to and tissue to of with a of and and with and of neutrophil extracellular traps in is in lung to and a of neutrophil extracellular traps in is in lung the and of the in to NETs and and to the of NETs and the of with the and in and also of lung and and and the of and a in of neutrophil extracellular traps in is in to of the to of and to the and to the of and in lung the and the of in of the number of the of NETs and with of of to the and the of and of the of of lung patients with of this in severe respiratory a of a and of and in the in the and in of damage number of and among the lung in the of the in the infiltrates in the to and NETs in in lung tissue and the a and neutrophil the and local of and a of the tissue a of in the and in and of in NETs seen in the lung the also seen in NETs in lung NETs in the of patients with to NETs to in the in the NETs in of patients in viral neutrophil and this to viral SARS-CoV-2 viral and NETs in lung tissue number of the SARS-CoV-2 also SARS-CoV-2 and NETs the viral and in tissue may of the their and of NETs and the of SARS-CoV-2 in lung patients with COVID-19. of the of NETs and lung tissue viral of NETs and the number of with SARS-CoV-2 in neutrophil extracellular the of to associated with with of of with of and of inflammatory of the also to with NETs in lung tissue and of the of the of may also the of the in IL-8 and in IL-8 a a and a a of IL-8 in the lung tissue and with the local IL-8 IL-8 in and and in of IL-8 associated with the local NETs in lung in and in neutrophil extracellular traps in the lung in NETs also to in IL-8 IL-8 and NETs in lung of patients with COVID-19. of lung tissue with a of NETs are in the and the and lung tissue IL-8 seen and the of lung tissue with a of lung tissue a of IL-8 the NETs and in IL-8 in lung tissue of the are shown in neutrophil extracellular IL-8 and NETs in patients with COVID-19. and of lung tissue in a of the a of NETs are the and IL-8 is in the of the are shown in neutrophil extracellular of and in NETs have been shown to with the of of neutrophil extracellular traps in is and chemokine neutrophil extracellular traps with may in cytotoxic are in the against lung and a of NETs and in in the and in the the the of in NETs to of of of in to a of to of and NETs in the lung tissue of patients with COVID-19. of lung tissue with a of to have of lung tissue with a of neutrophil and are with NETs and in of the are shown in and neutrophil extracellular inflammation is pathogenic in the pneumonitis associated with severe COVID-19. and are among the most abundantly present leukocytes in the lung inflammatory SARS-CoV-2 and in are in is to local lung inflammation and of inflammation is tissue damage and and in SARS-CoV-2 a neutrophil in lung patients with COVID-19. of the neutrophil also lung tissue and may a to with severe lung tissue damage and with of have been in the of patients with neutrophil extracellular traps mediate extracellular traps the lung and in severe and tissue in extracellular traps to in respiratory in a and NETs are a in the of patients with COVID-19. to the neutrophil NETs also and with a to tissue viral the of NETs associated with local IL-8 a a the of NETs and the of to present in pneumonitis and and tissue in of of the IL-8 (CXCL8) is a chemokine of to NETs in a and in NETs and local IL-8 of this chemokine in in and chemokine neutrophil extracellular traps with neutrophil extracellular traps inflammation and IL-8 is to and in to in the NETs in the tissue the of in severe respiratory a of to local also been shown to in and tissue in to also play a role in the lung SARS-CoV-2 been shown to in neutrophil extracellular traps mediate this NETs and tissue viral may the of the and NETs in the lung of to to the inflammatory to the of the in a SARS-CoV-2 lung also to seen and neutrophil extracellular traps in of with may play a role in respiratory failure their tissue-damaging properties inherent to neutrophil the of to lung NETs seen in role neutrophil extracellular traps in to and in neutrophil extracellular traps in and NETs in patients with COVID-19. IL-8 the may and may inflammation and extracellular traps to in respiratory to with the the with are in of of in with in of of of and of and and are a in are also in patients with and been shown to in neutrophil extracellular traps mediate to in the of this is are to the and with the to extracellular with are also and with of are in of to of of of of of the the the the may is a and of severe in the and this to with IL-8 and with in the NETs with to are to to patients SARS-CoV-2 to to but NETs and under and neutrophil extracellular traps (NETs) in lung tissue damage in severe NETs in lung patients with COVID-19. of the to viral and with local of the IL-8 chemokine the and chemokine is to and to this of tissue in NETs to the of the of NETs in the patients with NETs are to pathogenic in tissue damage and and to with neutrophil the IL-8 is to associated with the and and is associated with NETs in of patients with COVID-19. are in and and are also under the to also to this and neutrophil extracellular traps (NETs) in lung tissue damage in severe NETs in lung patients with COVID-19. of the to viral and with local of the IL-8 chemokine the and chemokine is to and to this of tissue in NETs to the of the of NETs in the patients with NETs are to pathogenic in tissue damage and and to with neutrophil the IL-8 is to associated with the and and is associated with NETs in of patients with COVID-19. are in and and are also under the to also to this and neutrophil extracellular traps (NETs) in lung tissue damage in severe NETs in lung patients with COVID-19. of the to viral and with local of the IL-8 chemokine the and chemokine is to and to this of tissue in NETs to the of the of NETs in the patients with NETs are to pathogenic in tissue damage and and to with neutrophil the IL-8 is to associated with the and and is associated with NETs in of patients with COVID-19. are in and and are also under the to also to this SARS-CoV-2 is in to of this been with the of associated with in and in of of a in with viral tissue are a local and inflammatory viral and of of tissue damage to to inflammation to in to tissue patients with a of damage associated with to and of inflammation and of in severe respiratory a of with of the and in of and is associated with is a of respiratory and lung inflammation in severe the of of inflammatory and and of Neutrophils are in the of patients with of the their role in neutrophil-associated the of inflammatory and are in the extracellular traps (NETs) are the of a form of neutrophil and NETs in a against and extracellular traps and neutrophil extracellular traps in to Neutrophils their with and a defense mechanism to and NETs are also in a of lung extracellular traps in lung and NETs with extracellular and in NETs are of to neutrophil and are the and inflammatory have been shown to and IL-8 are among the most and NETs in a against and SARS-CoV-2 also been shown to neutrophil extracellular traps mediate patients with COVID-19, NETs have been in the and lung the and and in neutrophil extracellular traps mediate of neutrophil extracellular traps in the respiratory of patients with extracellular traps the lung and in severe neutrophil extracellular traps in NETs have been pathogenic in COVID-19. this a of lung and patients with COVID-19. to and NETs to the of NETs and with tissue SARS-CoV-2 viral and the of local IL-8 and Design and the of the of with a a the of the of the to lung patients with a of severe and in severe respiratory a of tissue and a the of patients with the of in this and of the patients with and are in patients with to a of and are in are shown in lung patients lung and to also and tissue the SARS-CoV-2 and a SARS-CoV-2 of the SARS-CoV-2 with a of SARS-CoV-2 with the a and with a and with the of number of a of the number of IL-8 of IL-8 in tissue the to and IL-8 of the of IL-8 in the of of the IL-8 of IL-8 in tissue with a and with and is in and in of neutrophil extracellular traps in is in lung the and of in a tissue a a a a to a and and a to a to a to a to a a to and tissue to of with a of and and with and of neutrophil extracellular traps in is in lung to and a of neutrophil extracellular traps in is in lung the and of the in to NETs and and to the of NETs and the of with the and in and also of lung and and and the of and a in of neutrophil extracellular traps in is in to of the to of and to the and to the of and in lung the and the of in of the number of the of NETs and with of of to the and the of and of the of the of with a a the of the of the to the of the of with a a the of the of the to lung patients with a of severe and in severe respiratory a of tissue and a the of patients with the of in this and of the patients with and are in patients with to a of and are in are shown in lung patients lung and to also lung patients with a of severe and in severe respiratory a of tissue and a the of patients with the of in this and of the patients with and are in patients with to a of and are in are shown in lung patients lung and to also and tissue the SARS-CoV-2 and a SARS-CoV-2 of the SARS-CoV-2 with a of tissue the SARS-CoV-2 and a SARS-CoV-2 of the SARS-CoV-2 with a of SARS-CoV-2 with the a and with a and with the of number of a of the number of with the a and with a and with the of number of a of the number of IL-8 of IL-8 in tissue the to and IL-8 of the of IL-8 in the of of the of IL-8 in tissue the to and IL-8 of the of IL-8 in the of of the IL-8 of IL-8 in tissue with a and with and is in of IL-8 in tissue with a and with and is in and in of neutrophil extracellular traps in is in lung the and of in a tissue a a a a to a and and a to a to a to a to a a to and tissue to of with a of and and with and of neutrophil extracellular traps in is in lung to and in of neutrophil extracellular traps in is in lung the and of in a tissue a a a a to a and and a to a to a to a to a a to and tissue to of with a of and and with and of neutrophil extracellular traps in is in lung to and a of neutrophil extracellular traps in is in lung the and of the in to NETs and and to the of NETs and the of with the and in and also of lung and and and the of and a in of neutrophil extracellular traps in is in to of the to of and to the and to the of and in lung the and the of in of the number of a of neutrophil extracellular traps in is in lung the and of the in to NETs and and to the of NETs and the of with the and in and also of lung and and and the of and a in of neutrophil extracellular traps in is in to of the to of and to the and to the of and in lung the and the of in of the number of the of NETs and with of of to the and the of and of the of NETs and with of of to the and the of and of the of of lung patients with of this in severe respiratory a of a and of and in the in the and in of damage number of and among the lung in the of the in the infiltrates in the to and NETs in in lung tissue and the a and neutrophil the and local of and a of the tissue a of in the and in and of in NETs seen in the lung the also seen in NETs in lung NETs in the of patients with to NETs to in the in the NETs in of patients in viral neutrophil and this to viral SARS-CoV-2 viral and NETs in lung tissue number of the SARS-CoV-2 also SARS-CoV-2 and NETs the viral and in tissue may of the their and the of to associated with with of of with of and of inflammatory of the also to with NETs in lung tissue and of the of the of may also the of the in IL-8 and in IL-8 a a and a a of IL-8 in the lung tissue and with the local IL-8 IL-8 in and and in of IL-8 associated with the local NETs in lung in and in neutrophil extracellular traps in the lung in NETs also to in IL-8 IL-8 and NETs in lung of patients with COVID-19. of lung tissue with a of NETs are in the and the and lung tissue IL-8 seen and the of lung tissue with a of lung tissue a of IL-8 the NETs and in IL-8 in lung tissue of the are shown in neutrophil extracellular IL-8 and NETs in patients with COVID-19. and of lung tissue in a of the a of NETs are the and IL-8 is in the of the are shown in neutrophil extracellular of and in NETs have been shown to with the of of neutrophil extracellular traps in is and chemokine neutrophil extracellular traps with may in cytotoxic are in the against lung and a of NETs and in in the and in the the the of in NETs to of of of in to a of to of and NETs in the lung tissue of patients with COVID-19. of lung tissue with a of to have of lung tissue with a of neutrophil and are with NETs and in of the are shown in and neutrophil extracellular Neutrophils the of of lung patients with of this in severe respiratory a of a and of and in the in the and in of damage number of and among the lung in the of the in the infiltrates of lung patients with of this in severe respiratory a of a and of and in the in the and in of damage number of and among the lung in the of the in the infiltrates in the to and NETs in in lung tissue and the a and neutrophil the and local of and a of the tissue a of in the and in and of in NETs seen in the lung the also seen in NETs in lung NETs in the of patients with to NETs to in the in the NETs in of patients to and NETs in in lung tissue and the a and neutrophil the and local of and a of the tissue a of in the and in and of in NETs seen in the lung the also seen in NETs in lung NETs in the of patients with to NETs to in the in the NETs in of patients in viral neutrophil and this to viral SARS-CoV-2 viral and NETs in lung tissue number of the SARS-CoV-2 also SARS-CoV-2 and NETs the viral and in tissue may of the their and the of to associated with with of of with of and of inflammatory of the also to with NETs in lung tissue and of the of the of may also the of the viral neutrophil and this to viral SARS-CoV-2 viral and NETs in lung tissue number of the SARS-CoV-2 also SARS-CoV-2 and NETs the viral and in tissue may of the their and the of to associated with with of of with of and of inflammatory of the also to with NETs in lung tissue and of the of the of may also the of the in IL-8 and in IL-8 a a and a a of IL-8 in the lung tissue and with the local IL-8 IL-8 in and and in of IL-8 associated with the local NETs in lung in and in neutrophil extracellular traps in the lung in NETs also to in IL-8 IL-8 and NETs in patients with COVID-19. and of lung tissue in a of the a of NETs are the and IL-8 is in the of the are shown in neutrophil extracellular of and in NETs have been shown to with the of of neutrophil extracellular traps in is and chemokine neutrophil extracellular traps with may in cytotoxic are in the against lung and a of NETs and in in the and in the the the of in NETs to of of of in to a of to of and NETs in the lung tissue of patients with COVID-19. of lung tissue with a of to have of lung tissue with a of neutrophil and are with NETs and in of the are shown in and neutrophil extracellular in IL-8 a a and a a of IL-8 in the lung tissue and with the local IL-8 IL-8 in and and in of IL-8 associated with the local NETs in lung in and in neutrophil extracellular traps in the lung in NETs also to in IL-8 of and in NETs have been shown to with the of of neutrophil extracellular traps in is and chemokine neutrophil extracellular traps with may in cytotoxic are in the against lung and a of NETs and in in the and in the the the of in NETs to of of of in to a of to of inflammation is pathogenic in the pneumonitis associated with severe COVID-19. and are among the most abundantly present leukocytes in the lung inflammatory SARS-CoV-2 and in are in is to local lung inflammation and of inflammation is tissue damage and and in SARS-CoV-2 a neutrophil in lung patients with COVID-19. of the neutrophil also lung tissue and may a to with severe lung tissue damage and with of have been in the of patients with neutrophil extracellular traps mediate extracellular traps the lung and in severe and tissue in extracellular traps to in respiratory in a and NETs are a in the of patients with COVID-19. to the neutrophil NETs also and with a to tissue viral the of NETs associated with local IL-8 a a the of NETs and the of to present in pneumonitis and and tissue in of of the IL-8 (CXCL8) is a chemokine of to NETs in a and in NETs and local IL-8 of this chemokine in in and chemokine neutrophil extracellular traps with neutrophil extracellular traps inflammation and IL-8 is to and in to in the NETs in the tissue the of in severe respiratory a of to local also been shown to in and tissue in to also play a role in the lung SARS-CoV-2 been shown to in neutrophil extracellular traps mediate this NETs and tissue viral may the of the and NETs in the lung of to to the inflammatory to the of the in a SARS-CoV-2 lung also to seen and neutrophil extracellular traps in of with may play a role in respiratory failure their tissue-damaging properties inherent to neutrophil the of to lung NETs seen in role neutrophil extracellular traps in to and in neutrophil extracellular traps in and NETs in patients with COVID-19. IL-8 the may and may inflammation and extracellular traps to in respiratory to with the the with are in of of in with in of of of and of and and are a in are also in patients with and been shown to in neutrophil extracellular traps mediate to in the of this is are to the and with the to extracellular with are also and with of are in of to of of of of of the the the the may inflammation is pathogenic in the pneumonitis associated with severe COVID-19. and are among the most abundantly present leukocytes in the lung inflammatory SARS-CoV-2 and in are in is to local lung inflammation and of inflammation is tissue damage and and in SARS-CoV-2 a neutrophil in lung patients with COVID-19. of the neutrophil also lung tissue and may a to with severe lung tissue damage and with of NETs have been in the of patients with neutrophil extracellular traps mediate extracellular traps the lung and in severe and tissue in extracellular traps to in respiratory in a and NETs are a in the of patients with COVID-19. to the neutrophil NETs also and with a to tissue viral the of NETs associated with local IL-8 a a the of NETs and the of to present in pneumonitis and and tissue in of of the IL-8 (CXCL8) is a chemokine of to NETs in a and in NETs and local IL-8 of this chemokine in in and chemokine neutrophil extracellular traps with neutrophil extracellular traps inflammation and IL-8 is to and in to in the NETs in the tissue the of in severe respiratory a of to local also been shown to in and tissue in to also play a role in the lung SARS-CoV-2 been shown to in neutrophil extracellular traps mediate this NETs and tissue viral may the of the and NETs in the lung of to to the inflammatory to the of the in a SARS-CoV-2 lung also to seen and neutrophil extracellular traps in of with NETs may play a role in respiratory failure their tissue-damaging properties inherent to neutrophil the of to lung NETs seen in role neutrophil extracellular traps in to and in neutrophil extracellular traps in and NETs in patients with COVID-19. IL-8 the may and may inflammation and extracellular traps to in respiratory to with the the with are in of of in with in of of of and of and and are a in are also in patients with and been shown to in neutrophil extracellular traps mediate to in the of this is are to the and with the to extracellular with are also and with of are in of to of of of of of the the the the may is a and of severe in the and this to with IL-8 and with in the NETs with to are to to patients SARS-CoV-2 to to but NETs and under is a and of severe in the and this to with IL-8 and with in the NETs with to are to to patients SARS-CoV-2 to to but NETs and under and the and the and and the and to and the with have to the and and is a and is a is the is the a SARS-CoV-2 of role in the of the the and of the the of the the and the of the and and of of and of the SARS-CoV-2 and the of the to the of and are under with with with with with with with with
Melero et al. (Tue,) studied this question.